Results 191 to 200 of about 232,004 (343)
ABSTRACT Fine‐needle aspiration cytology specimens are frequently utilized for ancillary studies to identify diagnostic and prognostic information. This case highlights diagnostic pitfalls and challenges in diagnosing NUTM1‐rearranged neoplasia on pancreatic cytology.
Terrance J. Lynn
wiley +1 more source
The Major Role of Type 2 Inflammation in Asthma: From the Perspective of Immunological Mechanism. [PDF]
Cheng L, Sun L.
europepmc +1 more source
Bactericidal activity of eosinophil peroxidase. [PDF]
Elaine C. Jong +2 more
openalex +1 more source
ABSTRACT Malignant mesothelioma (MM) is a rare yet aggressive neoplasm that arises from mesothelial cells lining the thoracic and abdominal cavities, the pericardium, and the tunica testis. Characterized by rapid progression, high invasiveness, and a poor prognosis, MM poses significant clinical challenges. SMARCB1, also referred to as INI‐1, hSNF5, or
Jun Yang +4 more
wiley +1 more source
Innate Immune Pairing: Eosinophils as Hidden Architects of T Cell Immunity. [PDF]
Gupta K, Falta NA, Spencer LA.
europepmc +1 more source
Single-cell RNA-sequencing of human eosinophils in allergic inflammation in the esophagus [PDF]
Netali Ben-Baruch Morgenstern +11 more
openalex +1 more source
Urinary eosinophil-derived neurotoxin/protein X: A simple method for assessing eosinophil degranulation in vivo [PDF]
Vincent Cottin +3 more
openalex +1 more source
Analysis of SWI Complex Subunits in 69 Cases of TTF‐1 Negative Non‐Small Cell Lung Carcinoma
ABSTRACT Non‐small cell lung carcinomas, not otherwise specified (NSCLC‐NOS) with a specific signature including high‐grade hepatoid/clear cell morphology, negative lung panel mutational analysis, negative TTF‐1/Napsin A staining can be reported as a morphologic variant of an aggressive carcinoma with loss of one of the subunits of the SWI/SNF ...
Ramin Zargham +2 more
wiley +1 more source
Investigating blood eosinophil count thresholds in patients with COPD [PDF]
Richard Russell, Mona Bafadhel
openalex +1 more source

